ethambutol has been researched along with Lung Diseases in 78 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 25 (32.05) | 18.7374 |
1990's | 6 (7.69) | 18.2507 |
2000's | 15 (19.23) | 29.6817 |
2010's | 21 (26.92) | 24.3611 |
2020's | 11 (14.10) | 2.80 |
Authors | Studies |
---|---|
Chong, YP; Jo, KW; Lee, JH; Park, YE; Shim, TS | 1 |
Jhun, BW; Kim, BG; Kim, H; Kwon, OJ | 1 |
Brode, SK; Carlson, KF; Henkle, E; Ku, JH; Marino, M; Marras, TK; Winthrop, KL | 1 |
Enoki, Y; Fukunaga, K; Hasegawa, N; Kizu, J; Matsumoto, K; Namkoong, H; Ozawa, T; Taguchi, K; Takahashi, Y; Takaya, R | 1 |
Jiang, Y; Li, J; Shen, X; Wang, L; Xu, B; Yu, C; Zhang, Y; Zheng, X | 1 |
Boorgula, GD; Gumbo, T; Heysell, SK; Shankar, P; Singh, S; Srivastava, S | 1 |
Huh, HJ; Jhun, BW; Lee, NY; Moon, SM; Yoo, IY | 1 |
Cho, J; Han, SK; Kim, HJ; Kwak, N; Lee, CH; Lee, JS; Yim, JJ | 1 |
Chong, YP; Jo, KW; Kim, OH; Kwon, BS; Kwon, YS; Park, YE; Shim, TS | 1 |
Adachi, Y; Hayashi, S; Kagawa, T; Kobayashi, T; Kurahara, Y; Suzuki, K; Tsuyuguchi, K; Yoshida, S | 1 |
Aono, A; Fujiwara, K; Furuuchi, K; Kurashima, A; Mitarai, S; Morimoto, K; Ohta, K; Osawa, T; Shimoda, M; Takaki, A; Uesugi, F | 1 |
Ando, T; Kage, H; Matsumoto, Y; Nagase, T; Zokumasu, K | 1 |
Boeree, MJ; Danho, R; Hoefsloot, W; Kuipers, S; Pennings, LJ; Schildkraut, JA; Svensson, EM; van Ingen, J; Wertheim, HFL; Zweijpfenning, SMH | 1 |
Brás, S; Carvalho, R; Mendes-Bastos, P | 1 |
Guan, W; LaZhou, C; Lin, S; Shi, Y | 1 |
Kamii, Y; Kawashima, M; Kohno, S; Matsuki, M; Nagai, H; Nagoshi, S; Ohgiya, M; Ohta, K; Sato, A | 1 |
Choe, J; Daley, CL; Huh, HJ; Jeon, K; Jhun, BW; Koh, WJ; Kwon, OJ; Lee, NY; Moon, SM | 1 |
Cho, SN; Jeon, K; Kim, SY; Koh, WJ; Kwon, OJ; Park, HY; Shin, SJ | 1 |
Patsche, CB; Svensson, E; Wejse, C | 1 |
Daley, CL; Huh, HJ; Jeon, K; Jeong, BH; Ki, CS; Kim, SY; Koh, WJ; Lee, NY; Park, HY; Shin, SJ | 1 |
Escalon, JG; Hissong, E; Kaner, RJ; Legasto, AC; Momtahen, S; O'Beirne, SL; Port, JL; Schenck, EJ | 1 |
Betsuyaku, T; Goto, H; Hasegawa, N; Hayashi, Y; Hoshino, Y; Ishii, M; Izumi, K; Kurashima, A; Matsuda, S; Morimoto, K; Morino, E; Nakagawa, T; Namkoong, H; Nishimura, T; Ogawa, K; Sasaki, Y; Shiraishi, Y; Takasaki, J; Yoshiyama, T | 1 |
Andréjak, C; Chabot, F; Godbert, B; Hermann, J; Huet, D; Zordan, JM | 1 |
Lesic, AR; Pesut, DP; Stevic, RS; Stjepanovic, MI | 1 |
Kadota, JI; Kurashima, A; Suzuki, K | 1 |
Alcaide, F; Casas, S; Dorca, J; Gonzalez, L; Guerra, MR; Lopez, M; Santin, M | 1 |
Fukunaga, K; Hasegawa, N; Ishii, K; Ishizaka, A; Miyairi, M; Nishimura, T; Ohtani, S; Takeshita, K; Tasaka, S; Urano, T | 1 |
Anderson, PB; Blades, Z; Jarry, H; McCabe, J; McGrath, EE | 1 |
Randhawa, K; Smethurst, P; Soo Hoo, GW | 1 |
Jeon, K; Koh, WJ; Kwon, OJ; Park, HY; Sim, YS; Suh, GY | 1 |
Fujita, M; Harada, E; Ikegame, S; Kajiki, A; Matsumoto, T; Miyazaki, M; Nakanishi, Y; Ouchi, H; Tao, Y; Uchino, J; Watanabe, K | 1 |
Benoit, JP; Bertrand, JB; Coignard, S; Cosson, MA; Goulvestre, C; Martin, C; Morand, PC; Moro, MR; Picard, C; Poyart, C; Silvera, S; Veziris, N | 1 |
Jeon, K; Jeong, BH; Koh, WJ; Lee, SY; Shin, SJ | 1 |
Gochi, M; Kaneko, Y; Kinoshita, A; Kuwano, K; Saitou, Z; Samejima, T; Seki, A; Seki, Y; Takeda, H | 1 |
Campbell, IA; Jenkins, PA | 1 |
Kobashi, Y; Matsushima, T | 1 |
Cowie, RL; Field, SK | 1 |
Brown-Elliott, BA; Griffith, DE; Wallace, RJ | 1 |
Brown-Elliott, BA; Griffith, DE; Griffith, L; McLarty, J; Shepherd, S; Wallace, RJ | 1 |
Berthold, F; Ebeling, O; Handrick, W; Schwede, I; Wogawa, B | 1 |
Fujiwara, K | 1 |
Baum, GL; Daniele, B; Kramer, MR; Lavy, A; Priess, R; Raz, M; Shitrit, AB; Shitrit, D; Shlomi, D | 1 |
Banks, J; Campbell, IA; Hunter, AM; Jenkins, PA; Smith, AP | 1 |
Al Jarad, N; Barnes, NC; Demertzis, P; Empey, DW; Gaya, H; Hughes, DT; Jones, DJ; Rudd, RM; Wedzicha, JA | 1 |
Heginbothom, ML; Magee, JT | 1 |
Benator, DA; Gordin, FM; Kan, V | 1 |
Brown, BA; Couch, L; Girard, WM; Griffith, DE; Murphy, DT; Wallace, RJ | 1 |
Chien, HP; Huang, ST; Lin, TP; Wu, IH; Yu, MC | 1 |
Brown, BA; Cegielski, P; Griffith, DE; Murphy, DT; Wallace, RJ | 1 |
Brown, BA; Couch, LA; Girard, WM; Griffith, BE; Griffith, DE; Wallace, RJ | 1 |
Heginbothom, ML | 1 |
Amthor, M; Burkhardt, U; Ernst, M; Richter, E; Rosahl, W; Rüsch-Gerdes, S; Schreiber, J; Zugehör, M | 1 |
Beechler, CR; Fuller, SA; Ohashi, DK; Tellis, CJ | 1 |
Campbell, PB | 1 |
Bentz, RR; Schork, MA; Sodeman, TM; Tsang, AY | 1 |
Eĭsaev, BA; Rudoĭ, NM; Zankisova, IG | 1 |
Harris, GD; Johnason, WG; Nicholson, D | 1 |
Cole, FM; Kahana, LM; Richardson, H | 1 |
Francis, PB; Jay, SJ; Johanson, WG | 1 |
Heller, RM; Holden, KR | 1 |
Harris, GD; Johanson, WG; Nicholson, DP | 1 |
Lattimer, JK; Wechsler, M | 1 |
Ichiyama, S; Miyachi, T; Tsukamura, M | 1 |
Hammond, MD; Tonner, JA | 1 |
Calder, MA; France, AJ; McLeod, DT; Seaton, A | 1 |
Banks, J; Jenkins, PA; Smith, AP | 1 |
Wolinsky, E | 1 |
Davey, ME | 1 |
Duffy, JP; Elston, HR | 1 |
Gacad, G; Massaro, D | 1 |
Kerby, G; Rauscher, CR; Ruth, WE | 1 |
Zorini, AO | 1 |
Toyohara, M; Yamaguchi, T | 1 |
Collet, A; Devulder, B; Martin, JC; Tacquet, A | 1 |
Boccitto, G; Sbampato, M; Sternini, N | 1 |
Baba, M | 1 |
3 review(s) available for ethambutol and Lung Diseases
Article | Year |
---|---|
Nontuberculous mycobacteria and the lung: from suspicion to treatment.
Topics: Ethambutol; Female; Humans; Lung Diseases; Macrolides; Male; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Rifamycins | 2010 |
Mycobacterium szulgai infection of the lung: case report and review of an unusual pathogen.
Topics: Anti-Bacterial Agents; Ciprofloxacin; Drug Therapy, Combination; Ethambutol; Humans; Isoniazid; Lung Diseases; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium; Mycobacterium Infections; Radiography; Rifampin | 1997 |
Pulmonary disease caused by Mycobacterium terrae complex.
Topics: Chronic Disease; Ethambutol; Humans; Klebsiella Infections; Lung Diseases; Male; Middle Aged; Mycobacterium Infections; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Radiography; Rifampin; Time Factors | 1989 |
8 trial(s) available for ethambutol and Lung Diseases
Article | Year |
---|---|
Lower dose of ethambutol may reduce ocular toxicity without radiological deterioration for Mycobacterium avium complex pulmonary disease.
Topics: Anti-Bacterial Agents; Antitubercular Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Ethambutol; Humans; Lung Diseases; Macrolides; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Retrospective Studies; Rifampin; Toxic Optic Neuropathy | 2021 |
The clinical efficacy and safety of a fluoroquinolone-containing regimen for pulmonary MAC disease.
Topics: Aged; Antitubercular Agents; Clarithromycin; Drug Therapy, Combination; Ethambutol; Female; Fluoroquinolones; Gatifloxacin; Humans; Lung Diseases; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Rifampin; Treatment Outcome | 2012 |
Pulmonary disease caused by Mycobacterium xenopi in HIV-negative patients: five year follow-up of patients receiving standardised treatment.
Topics: Adult; Aged; Aged, 80 and over; Antitubercular Agents; Drug Resistance, Bacterial; Drug Therapy, Combination; Ethambutol; Female; Follow-Up Studies; HIV Seronegativity; Humans; Isoniazid; Lung Diseases; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Mycobacterium xenopi; Radiography; Recurrence; Rifampin; Sputum; Survival Analysis; Treatment Outcome | 2003 |
The effect of combined therapy according to the guidelines for the treatment of Mycobacterium avium complex pulmonary disease.
Topics: Adult; Aged; Aged, 80 and over; Antitubercular Agents; Clarithromycin; Drug Therapy, Combination; Ethambutol; Female; Humans; Lung Diseases; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Practice Guidelines as Topic; Prospective Studies; Rifampin; Streptomycin; Treatment Outcome | 2003 |
Thrice-weekly clarithromycin-containing regimen for treatment of Mycobacterium kansasii lung disease: results of a preliminary study.
Topics: Anti-Bacterial Agents; Antitubercular Agents; Clarithromycin; Drug Therapy, Combination; Ethambutol; Female; Humans; Lung Diseases; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Mycobacterium kansasii | 2003 |
Initial (6-month) results of three-times-weekly azithromycin in treatment regimens for Mycobacterium avium complex lung disease in human immunodeficiency virus-negative patients.
Topics: Anti-Bacterial Agents; Azithromycin; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Female; Humans; Lung Diseases; Male; Middle Aged; Mycobacterium avium-intracellulare Infection; Prospective Studies; Rifabutin; Streptomycin; Treatment Outcome | 1998 |
Early results (at 6 months) with intermittent clarithromycin-including regimens for lung disease due to Mycobacterium avium complex.
Topics: Adult; Aged; Aged, 80 and over; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Female; Follow-Up Studies; HIV Seronegativity; Humans; Lung Diseases; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Prospective Studies; Rifabutin; Sputum; Treatment Outcome | 2000 |
Pulmonary disease caused by Mycobacterium avium-intracellulare in HIV-negative patients: five-year follow-up of patients receiving standardised treatment.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antitubercular Agents; Drug Resistance, Multiple, Bacterial; Drug Therapy, Combination; Ethambutol; Female; HIV Seronegativity; Humans; Isoniazid; Lung Diseases; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Prospective Studies; Radiography, Thoracic; Rifampin; Sputum; Treatment Outcome | 2002 |
67 other study(ies) available for ethambutol and Lung Diseases
Article | Year |
---|---|
Efficacy of Fluoroquinolones as Substitutes for Ethambutol or Rifampin in the Treatment of Mycobacterium avium Complex Pulmonary Disease According to Radiologic Types.
Topics: Anti-Bacterial Agents; Drug Therapy, Combination; Ethambutol; Fluoroquinolones; Humans; Lung Diseases; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Retrospective Studies; Rifampin | 2022 |
Treatment outcomes of Mycobacterium avium complex pulmonary disease according to disease severity.
Topics: Aged; Animals; Antitubercular Agents; Body Mass Index; Ethambutol; Female; Humans; Lung; Lung Diseases; Male; Mycobacterium avium; Severity of Illness Index; Sputum; Treatment Outcome; Tuberculosis, Avian | 2022 |
Evaluation of Mycobacterium Avium Complex Pulmonary Disease Treatment Completion and Adherence to ATS/IDSA Guidelines.
Topics: Aged; Amikacin; Anti-Bacterial Agents; Drug Resistance, Bacterial; Drug Therapy, Combination; Ethambutol; Female; Humans; Lung Diseases; Macrolides; Male; Medicare; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Rifamycins; United States | 2023 |
Analysis of adverse drug events in pulmonary Mycobacterium avium complex disease using spontaneous reporting system.
Topics: Clarithromycin; Drug-Related Side Effects and Adverse Reactions; Ethambutol; Humans; Japan; Lung Diseases; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Rifampin | 2022 |
Drug resistance profile of Mycobacterium kansasii clinical isolates before and after 2-month empirical antimycobacterial treatment.
Topics: Anti-Bacterial Agents; Antitubercular Agents; China; Ethambutol; Humans; Isoniazid; Lung Diseases; Microbial Sensitivity Tests; Mycobacterium kansasii; Retrospective Studies; Rifampin; Tuberculosis | 2023 |
Isoniazid pharmacokinetics/pharmacodynamics as monotherapy and in combination regimen in the hollow fiber system model of Mycobacterium kansasii.
Topics: Antitubercular Agents; Ethambutol; Humans; Isoniazid; Lung Diseases; Microbial Sensitivity Tests; Mycobacterium kansasii; Mycobacterium tuberculosis | 2023 |
Intermittent Treatment with Azithromycin and Ethambutol for Noncavitary Mycobacterium avium Complex Pulmonary Disease.
Topics: Antitubercular Agents; Azithromycin; Body Mass Index; Drug Therapy, Combination; Ethambutol; Female; Humans; Lung Diseases; Male; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Odds Ratio; Treatment Outcome | 2019 |
Role of ethambutol and rifampicin in the treatment of Mycobacterium avium complex pulmonary disease.
Topics: Adult; Aged; Antibiotics, Antitubercular; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; Follow-Up Studies; Humans; Lung Diseases; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Radiography, Thoracic; Retrospective Studies; Rifampin; Time Factors; Treatment Outcome; Young Adult | 2019 |
Treatment Outcomes after Discontinuation of Ethambutol due to Adverse Events in
Topics: Aged; Antitubercular Agents; Ethambutol; Female; Fluoroquinolones; Humans; Lung Diseases; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Republic of Korea; Retrospective Studies; Tertiary Care Centers; Treatment Outcome | 2020 |
Effective treatment for clarithromycin-resistant Mycobacterium avium complex lung disease.
Topics: Aged; Antitubercular Agents; Clarithromycin; Drug Resistance, Bacterial; Drug Therapy, Combination; Ethambutol; Female; Humans; Japan; Lung; Lung Diseases; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Prognosis; Respiratory Tract Infections; Retrospective Studies; Rifampin; Sputum; Tomography, X-Ray Computed; Treatment Outcome | 2020 |
Mycobacterium europaeum lung disease in an immunocompetent patient without underlying lung disease.
Topics: Aged; Clarithromycin; Ethambutol; Female; Humans; Lung Diseases; Mycobacterium; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria | 2021 |
Mycobacterium Growth Indicator Tube Time-To-Positivity Can Serve As an Early Biomarker of Treatment Response in Mycobacterium avium Complex Pulmonary Disease.
Topics: Aged; Amikacin; Antitubercular Agents; Azithromycin; Biomarkers; Drug Therapy, Combination; Ethambutol; Female; Humans; Lung Diseases; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Retrospective Studies; Rifampin; Stem Cells | 2022 |
A fast-growing cold skin abscess revealing disseminated Mycobacterium intracellulare infection in an HIV-infected patient.
Topics: Abscess; Aged; AIDS-Related Opportunistic Infections; Antipruritics; Antitubercular Agents; Ethambutol; Female; HIV Infections; Humans; Loratadine; Lung Diseases; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Rifabutin; Skin Diseases, Bacterial; Treatment Outcome | 2018 |
Left lung hypoplasia with a right tuberculous pleural effusion after childbirth: A case report.
Topics: Abnormalities, Multiple; Adult; Antitubercular Agents; Ethambutol; Female; Humans; Isoniazid; Lung; Lung Diseases; Mycobacterium tuberculosis; Parturition; Pleural Effusion; Pregnancy; Pulmonary Heart Disease; Respiratory Insufficiency; Rifampin; Tomography, X-Ray Computed; Treatment Outcome; Tuberculosis, Pleural; Tuberculosis, Pulmonary | 2018 |
Adverse reactions associated with long-term drug administration in
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Drug Administration Schedule; Drug-Related Side Effects and Adverse Reactions; Ethambutol; Female; Humans; Japan; Logistic Models; Lung Diseases; Male; Middle Aged; Multivariate Analysis; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Retrospective Studies; Rifampin; Sputum; Time Factors; Young Adult | 2018 |
Treatment with a macrolide-containing regimen for Mycobacterium kansasii pulmonary disease.
Topics: Aged; Antitubercular Agents; Drug Therapy, Combination; Ethambutol; Female; Humans; Incidence; Isoniazid; Lung Diseases; Macrolides; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Mycobacterium kansasii; Nontuberculous Mycobacteria; Republic of Korea; Retrospective Studies; Rifampin; Tomography, X-Ray Computed; Treatment Outcome | 2019 |
Changes in serum immunomolecules during antibiotic therapy for Mycobacterium avium complex lung disease.
Topics: Aged; Anti-Bacterial Agents; Clarithromycin; Cytokines; Drug Therapy, Combination; Ethambutol; Female; Humans; Lung Diseases; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Prospective Studies; Rifampin; Th1 Cells; Th17 Cells; Th2 Cells | 2014 |
Disseminated Mycobacterium celatum disease with prolonged pulmonary involvement.
Topics: Aged; Anti-Bacterial Agents; Azithromycin; Ciprofloxacin; Clarithromycin; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Lung; Lung Diseases; Mycobacterium; Mycobacterium Infections; Pyrazinamide; Radiography | 2014 |
Response to Switch from Intermittent Therapy to Daily Therapy for Refractory Nodular Bronchiectatic Mycobacterium avium Complex Lung Disease.
Topics: Aged; Anti-Bacterial Agents; Bronchiectasis; Clarithromycin; Drug Therapy, Combination; Ethambutol; Female; Humans; Lung; Lung Diseases; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Sputum | 2015 |
Severe Cavitary, Fistulating Mycobacterium avium-intracellulare Complex Disease in an Immunocompetent Host.
Topics: Anti-Bacterial Agents; Azithromycin; Bronchial Fistula; Cysts; Ethambutol; Humans; Hydropneumothorax; Immunocompromised Host; Liver Diseases; Lung; Lung Diseases; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Pleura; Rifampin; Tomography, X-Ray Computed | 2015 |
Macrolide-Resistant Mycobacterium avium Complex Lung Disease: Analysis of 102 Consecutive Cases.
Topics: Aged; Anti-Bacterial Agents; Clarithromycin; Ethambutol; Female; Humans; Inappropriate Prescribing; Japan; Kaplan-Meier Estimate; Logistic Models; Lung Diseases; Macrolides; Male; Middle Aged; Multivariate Analysis; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Tuberculosis, Multidrug-Resistant | 2016 |
[Pulmonary infection with Mycobacterium malmoense. Difficulties in diagnosis and treatment].
Topics: Clarithromycin; Diagnosis, Differential; Ethambutol; Humans; Lung Diseases; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Respiratory Tract Infections; Rifampin; Tuberculosis, Pulmonary | 2017 |
Pulmonary and Vertebral Mycobacterium avium Disease in a HIV-negative 71-year-old Man - A Case Report.
Topics: Aged; Clarithromycin; Drug Therapy, Combination; Ethambutol; Fatal Outcome; Humans; Lung Diseases; Male; Mycobacterium avium; Mycobacterium Infections, Nontuberculous; Respiratory Insufficiency; Rifampin; Risk Factors; Spinal Diseases; Sputum | 2016 |
The clinical efficacy of a clarithromycin-based regimen for Mycobacterium avium complex disease: A nationwide post-marketing study.
Topics: Aged; Antitubercular Agents; Clarithromycin; Drug Therapy, Combination; Ethambutol; Female; Humans; Lung Diseases; Male; Marketing; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Retrospective Studies; Rifampin; Sputum; Treatment Outcome | 2017 |
Long-term relapses after 12-month treatment for Mycobacterium kansasii lung disease.
Topics: Adult; Antitubercular Agents; Cohort Studies; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Lung Diseases; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Mycobacterium kansasii; Recurrence; Retrospective Studies; Rifampin; Streptomycin | 2009 |
Therapeutic effects of various initial combinations of chemotherapy including clarithromycin against Mycobacterium avium complex pulmonary disease.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bronchiectasis; Clarithromycin; Dose-Response Relationship, Drug; Ethambutol; Female; Humans; Lung; Lung Diseases; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Retrospective Studies; Rifampin; Tomography, X-Ray Computed; Treatment Outcome | 2009 |
Nine-year progression of untreated pulmonary Mycobacterium szulgai infection.
Topics: Antitubercular Agents; Clarithromycin; Delayed Diagnosis; Disease Progression; Drug Therapy, Combination; Ethambutol; Humans; Lung Diseases; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria | 2010 |
Standardized combination antibiotic treatment of Mycobacterium avium complex lung disease.
Topics: Aged; Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Ethambutol; Female; Humans; Lung Diseases; Male; Middle Aged; Mycobacterium avium; Mycobacterium Infections; Retrospective Studies; Rifampin; Streptomycin; Treatment Outcome | 2010 |
Temporal interferon-gamma release response to Mycobacterium kansasii infection in an anorexia nervosa patient.
Topics: Anorexia Nervosa; Antibodies, Bacterial; Antitubercular Agents; Ethambutol; Female; Humans; Interferon-gamma; Isoniazid; Lung Diseases; Lymphocytes; Mycobacterium Infections, Nontuberculous; Mycobacterium kansasii; Rifampin; Young Adult | 2012 |
Therapeutic drug monitoring in the treatment of Mycobacterium avium complex lung disease.
Topics: Aged; Anti-Bacterial Agents; Antibiotics, Antitubercular; Clarithromycin; Drug Interactions; Drug Monitoring; Drug Therapy, Combination; Ethambutol; Female; Humans; Logistic Models; Lung Diseases; Male; Microbial Sensitivity Tests; Middle Aged; Multivariate Analysis; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Republic of Korea; Retrospective Studies; Rifabutin; Rifampin | 2012 |
[Mycobacterium xenopi lung infection in a patient with multiple lung cysts that responded well to chemotherapy: a case report].
Topics: Adult; Clarithromycin; Cysts; Ethambutol; Humans; Isoniazid; Lung Diseases; Male; Mycobacterium Infections, Nontuberculous; Mycobacterium xenopi; Rifampin; Tuberculosis, Pulmonary | 2012 |
Treatment of Mycobacterium avium-intracellulare complex lung disease with a macrolide, ethambutol, and clofazimine.
Topics: Aged; Aged, 80 and over; Antitubercular Agents; Clofazimine; Drug Therapy, Combination; Ethambutol; Female; Humans; Leprostatic Agents; Lung Diseases; Macrolides; Male; Middle Aged; Mycobacterium avium-intracellulare Infection | 2003 |
Ethambutol ocular toxicity in treatment regimens for Mycobacterium avium complex lung disease.
Topics: Aged; Aged, 80 and over; Antitubercular Agents; Drug Administration Schedule; Ethambutol; Eye Diseases; Female; Humans; Lung Diseases; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection | 2005 |
[Pulmonary infection due to Mycobacterium malmoense].
Topics: Azithromycin; Clarithromycin; Drug Therapy, Combination; Ethambutol; Humans; Lung Diseases; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Rifampin | 2005 |
[A case of Mycobacterium intracellulare lung disease that was detected by health examination and was successfully cured by chemotherapy--including discussions on the diagnostic criteria of the disease].
Topics: Antitubercular Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Ethambutol; Female; Humans; Lung Diseases; Magnetic Resonance Imaging; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Rifampin; Tomography, X-Ray Computed | 2005 |
Pulmonary Mycobacterium kansasii infection in Israel, 1999-2004: clinical features, drug susceptibility, and outcome.
Topics: Adult; Antibiotics, Antitubercular; Ciprofloxacin; Clarithromycin; Cycloserine; Ethambutol; Ethionamide; Female; Humans; Israel; Lung Diseases; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium Infections, Nontuberculous; Mycobacterium kansasii; Ofloxacin; Prognosis; Rifampin | 2006 |
Pulmonary infection with Mycobacterium kansasii in Wales, 1970-9: review of treatment and response.
Topics: Adult; Aged; Drug Therapy, Combination; Ethambutol; Female; Humans; Lung Diseases; Male; Middle Aged; Mycobacterium Infections; Mycobacterium Infections, Nontuberculous; Rifampin; Tuberculosis, Pulmonary | 1983 |
Mycobacterium kansasii pulmonary infection: a prospective study of the results of nine months of treatment with rifampicin and ethambutol. Research Committee, British Thoracic Society.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Female; Humans; Lung; Lung Diseases; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Prospective Studies; Radiography; Recurrence; Rifampin; Sputum | 1994 |
Comparison of characteristics of patients and treatment outcome for pulmonary non-tuberculous mycobacterial infection and pulmonary tuberculosis.
Topics: Acquired Immunodeficiency Syndrome; Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antibiotics, Antitubercular; Antitubercular Agents; Child; Drug Resistance; Drug Therapy, Combination; Ethambutol; Female; Humans; Lung Diseases; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Retrospective Studies; Rifampin; Treatment Outcome; Tuberculosis, Pulmonary | 1996 |
Pyrolysis mass spectrometry: a predictor of clinical response to treatment in pulmonary opportunist mycobacterial infection: preliminary work with M. malmoense.
Topics: Ethambutol; Humans; Lung Diseases; Mass Spectrometry; Microbial Sensitivity Tests; Mycobacterium Infections; Opportunistic Infections; Rifampin | 1997 |
Ethambutol-induced pulmonary infiltrates with fever and skin rash: a case report.
Topics: Antitubercular Agents; Drug Hypersensitivity; Ethambutol; Exanthema; Fever; Humans; Lung Diseases; Male; Middle Aged | 1998 |
Azithromycin-containing regimens for treatment of Mycobacterium avium complex lung disease.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Antibiotics, Antitubercular; Azithromycin; Drug Therapy, Combination; Drug Tolerance; Ethambutol; Female; Humans; Lung Diseases; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Prospective Studies; Rifabutin; Rifampin; Streptomycin; Treatment Outcome | 2001 |
The relationship between the in vitro drug susceptibility of opportunist mycobacteria and their in vivo response to treatment.
Topics: Antitubercular Agents; Ethambutol; Humans; In Vitro Techniques; Lung Diseases; Microbial Sensitivity Tests; Mycobacterium; Mycobacterium Infections; Opportunistic Infections; Predictive Value of Tests; Rifampin; Treatment Outcome | 2001 |
[Non-tubercular mycobacterial infection of the lungs due to Mycobacterium smegmatis].
Topics: Cardiopulmonary Resuscitation; CD4-Positive T-Lymphocytes; Clarithromycin; Drug Therapy, Combination; Ethambutol; Humans; Lung Diseases; Male; Middle Aged; Mycobacterium Infections, Nontuberculous; Mycobacterium smegmatis; Ofloxacin; Radiography; Rifabutin | 2001 |
Pulmonary disease caused by Mycobacterium xenopi:two case reports.
Topics: Adult; Bacteriological Techniques; Diagnosis, Differential; Ethambutol; Female; Humans; Isoniazid; Lung Diseases; Male; Middle Aged; Mycobacterium; Mycobacterium Infections | 1977 |
Defective leukotaxis in monocytes from patients with pulmonary tuberculosis.
Topics: Adolescent; Adult; Aged; Chemotaxis, Leukocyte; Chronic Disease; Dose-Response Relationship, Immunologic; Ethambutol; Female; Humans; Immunity, Cellular; In Vitro Techniques; Isoniazid; Lung Diseases; Lymphokines; Male; Middle Aged; Monocytes; Rifampin; Tuberculosis, Pulmonary; Zymosan | 1979 |
Combined vs. single-drug studies of susceptibilities of Mycobacterium kansasii to isoniazid, streptomycin, and ethambutol.
Topics: Ethambutol; Humans; Isoniazid; Lung Diseases; Microbial Sensitivity Tests; Mycobacterium; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Streptomycin | 1978 |
[Study of rifampicin in the treatment of tuberculosis and nonspecific inflammatory lung diseases].
Topics: Chronic Disease; Drug Evaluation; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Humans; Italy; Lung Diseases; Mycobacterium tuberculosis; Pneumonia; Poland; Postoperative Care; Rifampin; Time Factors; Tuberculosis, Pulmonary; Yugoslavia | 1975 |
Response to chemotherapy of pulmonary infection due to mycobacterium kansasii.
Topics: Adult; Drug Therapy, Combination; Ethambutol; Female; Follow-Up Studies; Humans; Isoniazid; Lung Diseases; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium Infections; Mycobacterium Infections, Nontuberculous; Rifampin; Texas | 1976 |
Clinical aspects of atypical mycobacterial infection.
Topics: Adult; Aged; Child, Preschool; Cycloserine; Diagnosis, Differential; Ethambutol; Ethionamide; Female; Humans; Isoniazid; Lung; Lung Diseases; Lymph Nodes; Lymphadenitis; Male; Mycobacterium Infections; Skin Tests; Sputum; Tuberculosis, Pulmonary | 1975 |
The course of untreated Mycobacterium kansasii disease.
Topics: Adult; Ethambutol; Female; Follow-Up Studies; Forced Expiratory Volume; Humans; Isoniazid; Lung Diseases; Male; Middle Aged; Mycobacterium; Mycobacterium Infections; Radiography; Rifampin; Vital Capacity | 1975 |
Childhood sarcoidosis. Progressive systemic illness with micronodular pulmonary involvement.
Topics: Child; Ethambutol; Female; Humans; Isoniazid; Lung Diseases; Prednisone; Radiography; Respiratory Insufficiency; Sarcoidosis | 1975 |
Response to chemotherapy of pulmonary infection due to Mycobacterium kansasii.
Topics: Adult; Drug Resistance, Microbial; Ethambutol; Female; Humans; Isoniazid; Lung Diseases; Male; Mycobacterium; Mycobacterium Infections; Recurrence; Rifampin; Sputum; Streptomycin; Time Factors | 1975 |
An evaluation of the current therapeutic regimen for renal tuberculosis.
Topics: Aminosalicylic Acids; Bilirubin; Color Perception; Cycloserine; Drug Evaluation; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Kidney; Liver; Lung Diseases; Male; Rifampin; Tuberculosis, Renal; Visual Perception | 1975 |
Superiority of enviomycin or streptomycin over ethambutol in initial treatment of lung disease caused by Mycobacterium avium complex.
Topics: Clinical Protocols; Drug Combinations; Enviomycin; Ethambutol; Female; Humans; Isoniazid; Lung Diseases; Male; Middle Aged; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Rifampin; Sputum; Streptomycin; Viomycin | 1989 |
Mycobacterium malmoense infections in Scotland: an increasing problem.
Topics: Adult; Aged; Aged, 80 and over; Antitubercular Agents; Drug Resistance, Microbial; Ethambutol; Female; Humans; Lung Diseases; Male; Middle Aged; Mycobacterium Infections; Scotland | 1987 |
Pulmonary infection with Mycobacterium malmoense--a review of treatment and response.
Topics: Adult; Aged; Antitubercular Agents; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Female; Humans; Isoniazid; Lung Diseases; Male; Middle Aged; Mycobacterium Infections; Patient Compliance; Rifampin; Sputum; Tuberculosis, Pulmonary | 1985 |
Nontuberculous mycobacterial infections of man.
Topics: Capreomycin; Child; Drug Resistance, Microbial; Ethambutol; Ethionamide; Humans; Isoniazid; Kanamycin; Lung Diseases; Lymphadenitis; Mycobacterium; Mycobacterium Infections; Rifampin; Skin Diseases, Infectious; Sputum; Streptomycin | 1974 |
Some clinical aspects and treatment of anonymous mycobacterial infections.
Topics: Aged; Diagnosis, Differential; Ethambutol; Humans; Lung Diseases; Male; Middle Aged; Mycobacterium; Mycobacterium Infections; Mycobacterium tuberculosis; Phenylthiourea; Radiography; Staining and Labeling; Tuberculin Test; Tuberculosis, Pulmonary | 1967 |
Mycobacterium xenopi and mycobacteriosis. A clinical bacteriologic report.
Topics: Antitubercular Agents; Bacteriological Techniques; Ethambutol; Humans; Isoniazid; Lung Diseases; Male; Microbial Sensitivity Tests; Middle Aged; Mycobacterium; Mycobacterium Infections; Radiography; Sputum; Streptomycin | 1973 |
Pulmonary fibrosis and group IV mycobacteria infection of the lungs in ankylosing spondylitis.
Topics: Adult; Autopsy; Ethambutol; Humans; Isoniazid; Lung Diseases; Male; Middle Aged; Mycobacterium; Mycobacterium Infections; Pulmonary Fibrosis; Respiratory Tract Infections; Spondylitis, Ankylosing; Sputum; Streptomycin | 1974 |
A ten-year clinical experience with Mycobacterium kansasii.
Topics: Adolescent; Adult; Aged; Aminosalicylic Acids; Antitubercular Agents; Child; Cycloserine; Ethambutol; Ethionamide; Female; Follow-Up Studies; Humans; Isoniazid; Lung Diseases; Male; Middle Aged; Mycobacterium; Mycobacterium Infections; Pneumonectomy; Pyrazinamide; Rifampin; Sputum; Streptomycin | 1974 |
[Report on the scientific and didactic activity of the Phtisiologic Clinic of the University of Rome, of the Center of Studies of the Sanatorium-Hospital Carlo Forlanini of the I.N.P.S. in the course of 1966].
Topics: Adult; Ethambutol; Gastrectomy; Humans; Italy; Lung Diseases; Lung Neoplasms; Mycobacterium tuberculosis; Sex Factors; Tuberculosis; Tuberculosis, Pulmonary | 1967 |
[Studies on discharge of atypical myocbacteria in ambulatory patients and treatment of pulmonary disease caused by atypical mycobacteria (so-called atypical mycobacteriosis)].
Topics: Adult; Ambulatory Care; Ethambutol; Humans; Lung Diseases; Male; Middle Aged; Mycobacterium; Mycobacterium Infections; Tuberculosis, Pulmonary | 1967 |
Activity of certain antibacillary substances in the experimental infection of guinea-pigs exposed to dust by Mycobacterium kansasii.
Topics: Animals; Coal; Dust; Ethambutol; Ethionamide; Guinea Pigs; Isoniazid; Lung Diseases; Mycobacterium; Mycobacterium Infections; Pneumoconiosis; Radiography | 1967 |
[Behavior of certain biologic parameters of hepatic and renal function during therapy with rifomycin B diethylamide (rifamide) administered by venous infusion].
Topics: Adult; Aged; Aminosalicylic Acids; Antitubercular Agents; Chronic Disease; Cycloserine; Empyema, Tuberculous; Ethambutol; Humans; Isonicotinic Acids; Kidney Function Tests; Liver Function Tests; Lung Diseases; Middle Aged; Morpholines; Pyrazines; Rifampin; Tuberculosis, Miliary; Tuberculosis, Pulmonary | 1968 |
[D-2, 2'-(ethylenediimino)-di-1-butanol therapy on pulmonary disease caused by "unclassified" mycobacteria (nonphotochromogen)].
Topics: Antitubercular Agents; Ethambutol; Humans; Lung Diseases; Mycobacterium | 1965 |